Approval Based Upon Phase 3 DeLLphi-304 Trial Demonstrating 40% Reduction in Risk of Death with IMDYLLTRA Compared to Chemotherapy Novel Treatment Option for Patients with Extensive-Stage Small Cell Lung Cancer That Has Progressed THOUSAND OAKS, Calif., June …